Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration. The FDA in the … [+6268 chars]Read More
FDA reversals leave investors worrying about the fates of other experimental drugs CNBC
